The excitement is starting to build for a lot of hot companies debuting on public markets this year, led by potential initial ...

SpaceX and OpenAI are preparing for blockbuster IPOs, but history says buying the stocks immediately is a risky move.

A trio of mega-exits could suck up all the air in the room, even as they also broke records for venture capital-backed tech ...

April 27 (Reuters) - Drug developers Seaport Therapeutics and Hemab Therapeutics launched their U.S. initial public offerings ...

Behind the scenes activity in the US IPO market is reaching a fever pitch, according to dealmakers, as companies lured by stock markets near record highs prepare to go public. The industry has been ...

The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...

Want in on the next big IPO? These brokers give everyday investors real access to IPO shares before they hit the open market.

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.

If passive fund mechanics are your jam, and mega-cap concentration risk is the bread you eat it on, what Steve Sosnik laid out recently on The Compound and Friends is one of the more unsettling ...

Through mid-November, the returns of initial public offerings have slowed, and the Renaissance IPO Index stands at a gain of 5.1% year to date, lagging the S&P 500 (up 16.4% by market price over the ...

With AI and big tech firms seeking to raise hundreds of billions in equity and debt this year to build data centers, any high ...

Goldman Sachs expects about 100 IPOs raising $160B in 2026, down from a prior forecast of 120 deals for the same total value, ...